PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Jan-2026 U.S. FDA Grants RMAT Designation to ECT204, an ARTEMIS® CAR (AbTCR) T-Cell Therapy for Advanced Hepatocellular Carcinoma Businesswire
12-Jan-2026 Hummingbird Diagnostics Names Vincent Lozada Chief Executive Officer Businesswire
12-Jan-2026 Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel) Businesswire
12-Jan-2026 PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia Businesswire
12-Jan-2026 Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones Businesswire
12-Jan-2026 Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors Businesswire
12-Jan-2026 Wilmington PharmaTech Appoints Seasoned Commercial Leader to Drive Growth Businesswire
12-Jan-2026 Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan Businesswire
12-Jan-2026 IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms Businesswire
12-Jan-2026 Vibrant Therapeutics Raises $61M and Appoints Han Lee, Ph.D. as Co-CEO Businesswire
12-Jan-2026 NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue Businesswire
12-Jan-2026 Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production Businesswire
12-Jan-2026 REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight Businesswire
12-Jan-2026 Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026 Businesswire
12-Jan-2026 SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer Businesswire
12-Jan-2026 Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference Businesswire
12-Jan-2026 TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance Businesswire
12-Jan-2026 Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer Businesswire
12-Jan-2026 Healthpeak Properties Announces $925 Million of Transaction Activity Businesswire
12-Jan-2026 Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Businesswire